ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9
January 13, 2025 09:00 ET
|
ERS Genomics
ERS Genomics (‘ERS’), the CRISPR licensing company, today announces the launch of its Express License platform.